A genome-wide association study identifies alleles in FGFR 2 associated with risk of sporadic postmenopausal breast cancer

David J. Hunter1,2,3,6, Peter Kraft2, Kevin B. Jacobs4, David G. Cox1,2, Meredith Yeager5,6, Susan E. Hankinson1, Sholom Wacholder6, Zhaoming Wang5,6, Robert Welch5,6, Amy Hutchinson5,6, Kai Yu6, Nilanjan Chatterjee6, Nick Orr7, Walter C. Willett1,8, Graham A. Colditz9, Regina G. Ziegler6, Christine D. Berg10, Saundra S. Buys11, Catherine A. McCarty12, Heather Spencer Feigelson13, Eugenia E. Calle13, Michael J. Thun13, Richard B. Hayes6, Margaret Tucker6, Daniela S. Gerhard14, Joseph F. Fraumeni Jr.6, Robert N. Hoover6, Gilles Thomas6, and Stephen J Chanock6,7 1Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 02115 2Program in Molecular and Genetic Epidemiology, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 3Broad Institute of Harvard and MIT 4Bioinformed Consulting Services, Gaithersburg, MD 5SAIC-Frederick, NCI-FCRDC, Frederick, MD 6Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services 7Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, DHHS 8Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 9Washington University School of Medicine, St. Louis, MO 10Division of Cancer Prevention, NCI, NIH, DHHS 11Department of Internal Medicine, University of Utah, Salt Lake City, UT 12The Center for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, WI 13Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA 30329 14Office of Cancer Genomics, NCI, NIH, DHHS